Main > ONCOLOGY (**) > Head & Neck>Squamous>C.>MET Or R > TREAT.: > USA. M. PembrolizuMAb > Indications> > >1st Line Treat.> > >MonoTherapy> > >Companion Diagnostics>

---

>Companion Diagnostics>'s subsections
>(*) USA Approval Date: 2019. 06.11
>Company
>Patent>UpDate: 2019. 12.31
>Patent>USA Patent APP.
>PR Web-Site
>TradeMark

>Companion Diagnostics>'s products
This section has no products